Physician profile
Steven E Canfield
NPI 1598797276
$256,126.81
in general payments reported to CMS, 2019-2025
38 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $14K · 2021: $7,976 · 2022: $14K · 2023: $56K · 2024: $61K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $161K · Consulting Fee: $9,470 · Food and Beverage: $5,719 · Travel and Lodging: $3,864 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,600 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $161,000.00 |
| Consulting Fee | $9,470.00 |
| Food and Beverage | $5,718.92 |
| Travel and Lodging | $3,864.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,600.00 |
| Education | $266.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $166,448.26 | 2022-2025 | Nanoknife, Nanoknife, Solero |
| Pfizer INC. | $53,575.24 | 2019-2025 | |
| Astellas Pharma US INC | $14,250.84 | 2019-2025 | Xtandi, Padcev |
| Progenics Pharmaceuticals, INC. | $12,431.82 | 2022-2023 | Pylarify |
| Ferring Pharmaceuticals INC. | $4,344.84 | 2019-2025 | Adstiladrin |
| Boston Scientific Corporation | $1,255.35 | 2019-2025 | General - Erectile Dysfunction, Lithovue, Rezum Generator |
| Ethicon US, LLC | $431.17 | 2020-2024 | Megadyne, Mega Soft, Echelon Flex |
| Coloplast Corp | $336.81 | 2020-2025 | Titan |
| Axonics, INC. | $308.17 | 2020-2022 | |
| Baxter Healthcare | $284.64 | 2020-2023 | Tisseel |
| Cook Medical LLC | $243.45 | 2019-2025 | Ncircle, Litho 150 |
| Allergan, INC. | $192.78 | 2019-2021 | |
| Abbvie INC. | $192.65 | 2019-2025 | Lupron Depot |
| Procept Biorobotics Corporation | $180.69 | 2019-2025 | |
| Medtronic, INC. | $168.12 | 2023 | Interstim |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $161.58 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $148.44 | 2019-2024 | |
| Myovant Sciences INC. | $144.86 | 2021-2022 | |
| Conmed Corporation | $117.53 | 2022 | |
| Genzyme Corporation | $116.87 | 2020 | |
| Edap Technomed INC | $112.50 | 2022 | |
| Urogen Pharma, INC. | $108.79 | 2022-2025 | Jelmyto |
| Travere Therapeutics, INC. | $96.21 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $74.27 | 2019-2021 | |
| Photocure INC | $59.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $57.99 | 2022-2025 | |
| Shire North American Group INC | $40.22 | 2019 | |
| Olympus America INC. | $31.37 | 2020-2021 | |
| Ambu INC. | $31.14 | 2021 | |
| Dendreon Pharmaceuticals LLC | $26.44 | 2019 | |
| Teleflex LLC | $26.40 | 2025 | Barrigel |
| Tetraphase Pharmaceuticals, INC. | $22.98 | 2019 | |
| Merck Sharp & Dohme LLC | $22.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $21.55 | 2021 | |
| Agiliti Surgical, INC. | $20.66 | 2024 | Quanta Cyberblade, Wolf Holep Scope Set |
| Sumitomo Pharma America, INC. | $16.16 | 2024 | Orgovyx |
| Covidien LP | $12.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Canfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.